DIMERIX LIMITED
Who is DIMERIX LIMITED?
Dimerix (ASX:DXB) is a clinical-stage biopharmaceutical company with a portfolio of drug candidates for inflammatory diseases, including kidney and respiratory diseases. Dimerix’ lead clinical asset, DMX-200 (or QYTOVRA® in some territories), is in Phase 3 trials as a treatment for focal segmental g...See more
Industry & Specialities
Pharmaceuticals
Manufacturing
Countries of Operation
Australia
Headquarters:
Australia
Company Type:
MNC / Large Enterprise
Company size:
1-10 Employees
Address:
MELBOURNE, VICTORIA 3000, AU
Employees by Department
- IT / Product (2)
- Sales (1)
- The Rest (6)
- Total (9)
Key Decision Makers
Hamish George
CFO/Company Secretary
Bronwyn Pollock
Vice President Product Development
Mrinal Murali
Clinical Project Manager
Corey Moors
Senior Business Development Associate
Employees by Seniority
C-level
4employees
Senior
2employees
Non-managers
3employees
Financials
LOW
spending power
Funding Status
Publicly listed on stock exchange
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- What is the funding status of DIMERIX LIMITED?
- Where is DIMERIX LIMITED's headquarter?
- What DIMERIX LIMITED's spending power?
- Does DIMERIX LIMITED have a presence in the domain it operates in?